#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transferrin decreased Pyruvate kinase deficiency anaemia Renal cell carcinoma Mitochondrial encephalomyopathy Hidradenitis Indolent systemic mastocytosis Stevens-Johnson syndrome Cystic fibrosis lung Central nervous system lymphoma Acquired C1 inhibitor deficiency Leiomyosarcoma metastatic Pustular psoriasis Medulloblastoma recurrent Propionic acidaemia Anal fistula More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Diagnostics Sjogren’s syndrome – Trials in Disease Bronchopulmonary dysplasia Piriformis syndrome – Treatment Richter’s syndrome – Diagnostics Primary biliary cholangitis – Life with Disease Marginal zone lymphoma refractory Turner’s syndrome – Life with Disease Paraneoplastic neurological syndrome – Diagnostics Mantle cell lymphoma stage III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Senicapoc A3907 Glutathione Ferric Carboxymaltose Quinine Dihydrochloride Warfarin Sodium IBANDRONIC ACID S-241656 Mometasone Furoate Ph. Eur. Edotreotide Anb032 XELAFASLATIDE Opevesostat Hydroxypropyl Cellulose Lf Temozolomide Gs-1427 Furosemide Ph. Eur. Paeonol IDOR-1117-2520C Df1001 More therapies…

    Learn about Your Condition

    Hypochromic anaemia Diffuse large B-cell lymphoma Oxygen therapy Metabolic syndrome Ichthyosis Pneumonia Chordoma Chondroplasty Fabry's disease Paget's disease of the vulva Staphylococcal infection Connective tissue disorder Glomerulonephritis chronic Ankylosing spondylitis Tumour thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Stella-Gyn s.r.o.

Stella-Gyn s.r.o.

Jiraskova 116, Vodnany, 389 01, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • A study comparing furazidin and clindamycin for women with bacterial vaginosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clindamycin Phosphate
    Czechia Italy Poland Slovakia
  • A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

    Recruiting

    2 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • GS-248
    • VIPOGLANSTAT
    Bulgaria Czechia Hungary Italy Poland Romania
  • Contraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • DROSPIRENONE
    Czechia Finland Hungary Poland Romania Spain +1
  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System vs. Desogestrel Tablets for Preventing Pregnancy in Women

    Not recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Desogestrel
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2
  • Study on the Impact of LF111 and Drospirenone on Bone Health in Adolescent and Adult Women Using Oral Contraceptives

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    Czechia Poland
  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2
  • Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    • Fezolinetant
    Czechia Denmark France Germany Hungary Italy +3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!